Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D04XGX
|
|||
Former ID |
DNC009121
|
|||
Drug Name |
2-(2-Methoxybenzyl)-3H-benzo[f]chromen-3-one
|
|||
Synonyms |
CHEMBL469340; 2-(2-Methoxybenzyl)-3H-benzo[f]chromen-3-one
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C21H16O3
|
|||
Canonical SMILES |
COC1=CC=CC=C1CC2=CC3=C(C=CC4=CC=CC=C43)OC2=O
|
|||
InChI |
1S/C21H16O3/c1-23-19-9-5-3-7-15(19)12-16-13-18-17-8-4-2-6-14(17)10-11-20(18)24-21(16)22/h2-11,13H,12H2,1H3
|
|||
InChIKey |
VCXYTPBLXWPGOC-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Cannabinoid receptor 2 (CB2) | Target Info | Inhibitor | [1] |
KEGG Pathway | Neuroactive ligand-receptor interaction | |||
Reactome | Class A/1 (Rhodopsin-like receptors) | |||
G alpha (i) signalling events | ||||
WikiPathways | GPCRs, Class A Rhodopsin-like | |||
Small Ligand GPCRs | ||||
GPCR ligand binding | ||||
GPCR downstream signaling |
References | Top | |||
---|---|---|---|---|
REF 1 | Synthesis and pharmacological evaluation of coumarin derivatives as cannabinoid receptor antagonists and inverse agonists. Bioorg Med Chem. 2009 Apr 1;17(7):2842-51. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.